-
Exclusive: VBI Vaccines CEO Talks Pipeline, Investor Backing, Hep. B Vaccine Opportunity
Monday, April 3, 2017 - 11:16am | 1001Read More...VBI Vaccines Inc. - Ordinary Shares (NASDAQ: VBIV) has emerged as one of the best performing small-cap biotech plays of the year, with shares of the Cambridge, Massachusetts-based company quietly jumping over 75 percent year-to-date. With several new vaccines in the pipeline, analysts believe there...
-
Meet VBI Vaccines, The Biotech Up 100% In 2017
Tuesday, March 7, 2017 - 1:30pm | 582Read More...If you've been too distracted by the Snap Inc (NYSE: SNAP) IPO lottery ticket trade to keep your eye on small-cap biotech moves, you may not have noticed VBI Vaccines, Inc. - Ordinary Shares (NASDAQ: VBIV) shares quietly doubling in value since the start of the year. VBI Vaccines is a...



